Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03130738 · ClinicalTrials.gov registry record · Phase 2
Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis
A Phase 2 study, sponsored by Hill Dermaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 65
- Enrollment target
NCT03130738 is a Phase 2 study that has completed, run by Hill Dermaceuticals. The registered enrollment target is 65 participants.
The verdict
NCT03130738, a Phase 2 study, has completed, sponsored by Hill Dermaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the efficacy and safety of active treatment (miconazole oil) for 7 versus 14 days, and to compare 14 days of active treatment (miconazole oil) to inactive treatment (placebo) over a 14-day treatment duration, in subjects with fungal infection (otomycosis) of the external ear.
Interventions
- DRUG 7-Day Miconazole Oil (Miconazole 2%)
- DRUG 14-Day Miconazole Oil (Miconazole 2%)
- DRUG 14-Day Placebo - Oil Vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2017-04-20 |
| Est. Completion | 2019-08-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03130738
The ClinicalTrials.gov registry entry for NCT03130738 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hill Dermaceuticals, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 7-Day Miconazole Oil (Miconazole 2%) is the first listed.
NCT03130738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03130738 about?
NCT03130738 is a clinical study titled "Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis". The purpose of the study is to evaluate the efficacy and safety of active treatment (miconazole oil) for 7 versus 14 days, and to compare 14 days of active treatment (miconazole oil) to inactive treatment (placebo) over a 14-day treatment duration, in subjects with fungal infection (otomycosis) of t...
What is the current status of trial NCT03130738?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 65 participants. The study started on 2017-04-20. Estimated completion is 2019-08-06.
What interventions are being tested in trial NCT03130738?
The interventions under investigation include: 7-Day Miconazole Oil (Miconazole 2%) (DRUG), 14-Day Miconazole Oil (Miconazole 2%) (DRUG), 14-Day Placebo - Oil Vehicle (DRUG).
Who is sponsoring clinical trial NCT03130738?
This trial is sponsored by Hill Dermaceuticals, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.